203987-26-2 Usage
Uses
Used in Pharmaceutical Industry:
(6-METHOXY-CHROMAN-3-YL)-METHYLAMINE is used as a potential therapeutic agent for its antioxidant properties, which can help combat oxidative stress-related conditions. Its anti-inflammatory effects make it a candidate for treating inflammatory diseases.
Used in Neuroprotective Applications:
In the field of neurology, (6-METHOXY-CHROMAN-3-YL)-METHYLAMINE is used as a neuroprotective agent due to its potential to shield the nervous system from damage, which could be beneficial in conditions such as neurodegenerative diseases.
Used in Anticancer Applications:
(6-METHOXY-CHROMAN-3-YL)-METHYLAMINE is used as an anticancer agent, where its potential to inhibit cancer cell growth and proliferation is being investigated. It may also have applications in enhancing the effectiveness of existing cancer treatments.
Used in Research and Development:
In the scientific community, (6-METHOXY-CHROMAN-3-YL)-METHYLAMINE serves as a subject of research for understanding its biological activities, which can lead to the development of new drugs and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 203987-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,9,8 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 203987-26:
(8*2)+(7*0)+(6*3)+(5*9)+(4*8)+(3*7)+(2*2)+(1*6)=142
142 % 10 = 2
So 203987-26-2 is a valid CAS Registry Number.
203987-26-2Relevant academic research and scientific papers
Substituted 3-amido and 3-amidoalkylbenzopyran derivatives: Synthesis and pharmacological activity as melatonin ligands
Viaud,Mamai,Guerin,Bennejean,Renard,Delagrange,Guardiola-Lemaitre,Howell,Guillaumet
, p. 47 - 56 (2007/10/03)
A novel series of melatonin analogues based on the benzopyran nucleus is described. These compounds are prepared in several steps from substituted 2-hydroxybenzaldehydes. Some of these derivatives competitively inhibit 2-[125I]iodomelatonin binding to chicken brain and ovine pars tuberalis membranes although with reduced affinity compared with melatonin.
